WHO ICTRP trial
Clinical study on the treatment of coronary heart disease with Guanxinning…
ChiCTR2500097864 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500097864 |
|---|---|
| Public title | Clinical study on the treatment of coronary heart disease with Guanxinning Tablet by regulating intestinal flora |
| Scientific title | Clinical study on the treatment of coronary heart disease with Guanxinning Tablet by regulating intestinal flora |
| Primary sponsor | Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Coronary heart disease |
| Interventions | Conventional treatment group:Western medicine basic treatment for secondary prevention of coronary heart disease;Test group:Take Guanxinning tablets orally |
| Registration date | Feb 26, 2025 |
| Target size | Conventional treatment group:25;Test group:25 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: